Regeneron Pharmaceuticals (REGN) Times Interest Earned (2017 - 2025)
Historic Times Interest Earned for Regeneron Pharmaceuticals (REGN) over the last 16 years, with Q4 2025 value amounting to $72.12.
- Regeneron Pharmaceuticals' Times Interest Earned fell 2352.14% to $72.12 in Q4 2025 from the same period last year, while for Dec 2025 it was $81.69, marking a year-over-year increase of 1299.11%. This contributed to the annual value of $81.69 for FY2025, which is 1299.11% up from last year.
- According to the latest figures from Q4 2025, Regeneron Pharmaceuticals' Times Interest Earned is $72.12, which was down 2352.14% from $53.2 recorded in Q3 2025.
- In the past 5 years, Regeneron Pharmaceuticals' Times Interest Earned registered a high of $299.86 during Q2 2025, and its lowest value of $46.67 during Q1 2024.
- Over the past 5 years, Regeneron Pharmaceuticals' median Times Interest Earned value was $74.24 (recorded in 2021), while the average stood at $98.15.
- In the last 5 years, Regeneron Pharmaceuticals' Times Interest Earned tumbled by 6479.51% in 2022 and then soared by 31491.63% in 2025.
- Regeneron Pharmaceuticals' Times Interest Earned (Quarter) stood at $187.21 in 2021, then crashed by 64.8% to $65.91 in 2022, then decreased by 19.34% to $53.16 in 2023, then surged by 77.38% to $94.3 in 2024, then decreased by 23.52% to $72.12 in 2025.
- Its last three reported values are $72.12 in Q4 2025, $53.2 for Q3 2025, and $299.86 during Q2 2025.